DELiveri®, a high-throughput screening platform for RNA therapeutics, ensures precise delivery with reduced toxicity across a wide range of cell types. Explore a case study on two membrane proteins ...
Molecular Cellular Pharmacology Graduate Program, University of Wisconsin-Madison, Madison, USA Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan ...
J&J said that the Ambrx ADC-generating platform can create stable drugs that are less likely to release their cytotoxic payloads early, which should help limit off-target toxicities - a common ...
1 Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai, Japan 2 Department of Thoracic Surgery, Institute of Development, Aging and ...